Literature DB >> 23599552

The human qualities needed to complete the global eradication of polio.

Dermot Maher1.   

Abstract

Although the 99% decrease seen in global polio incidence between 1988 and 2000 represented remarkable progress towards polio eradication, tackling the last 1% of polio has proved tantalizingly difficult. Pockets of endemic transmission currently persist both on the border between Afghanistan and Pakistan and in northern Nigeria. These pockets have permitted the reinfection of countries that were previously polio-free. Global strategic plans for polio eradication set out the activities, resources and financing needed to overcome the managerial, technical and security challenges faced by those tasked with the interruption of poliovirus transmission. However, polio eradication also depends on the less tangible but equally important human qualities of energy, realism, articulacy, determination, imagination, collaboration, adaptability, tactical awareness, innovation, openness and nimbleness (the initial letters of which give the acronym "ERADICATION"). By paying attention to these human qualities, the stakeholders involved may be more likely to achieve global polio eradication.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23599552      PMCID: PMC3629453          DOI: 10.2471/BLT.12.111831

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  14 in total

1.  Eradication of poliomyelitis in countries affected by conflict.

Authors:  R H Tangermann; H F Hull; H Jafari; B Nkowane; H Everts; R B Aylward
Journal:  Bull World Health Organ       Date:  2000       Impact factor: 9.408

2.  Initial sequencing and analysis of the human genome.

Authors:  E S Lander; L M Linton; B Birren; C Nusbaum; M C Zody; J Baldwin; K Devon; K Dewar; M Doyle; W FitzHugh; R Funke; D Gage; K Harris; A Heaford; J Howland; L Kann; J Lehoczky; R LeVine; P McEwan; K McKernan; J Meldrim; J P Mesirov; C Miranda; W Morris; J Naylor; C Raymond; M Rosetti; R Santos; A Sheridan; C Sougnez; Y Stange-Thomann; N Stojanovic; A Subramanian; D Wyman; J Rogers; J Sulston; R Ainscough; S Beck; D Bentley; J Burton; C Clee; N Carter; A Coulson; R Deadman; P Deloukas; A Dunham; I Dunham; R Durbin; L French; D Grafham; S Gregory; T Hubbard; S Humphray; A Hunt; M Jones; C Lloyd; A McMurray; L Matthews; S Mercer; S Milne; J C Mullikin; A Mungall; R Plumb; M Ross; R Shownkeen; S Sims; R H Waterston; R K Wilson; L W Hillier; J D McPherson; M A Marra; E R Mardis; L A Fulton; A T Chinwalla; K H Pepin; W R Gish; S L Chissoe; M C Wendl; K D Delehaunty; T L Miner; A Delehaunty; J B Kramer; L L Cook; R S Fulton; D L Johnson; P J Minx; S W Clifton; T Hawkins; E Branscomb; P Predki; P Richardson; S Wenning; T Slezak; N Doggett; J F Cheng; A Olsen; S Lucas; C Elkin; E Uberbacher; M Frazier; R A Gibbs; D M Muzny; S E Scherer; J B Bouck; E J Sodergren; K C Worley; C M Rives; J H Gorrell; M L Metzker; S L Naylor; R S Kucherlapati; D L Nelson; G M Weinstock; Y Sakaki; A Fujiyama; M Hattori; T Yada; A Toyoda; T Itoh; C Kawagoe; H Watanabe; Y Totoki; T Taylor; J Weissenbach; R Heilig; W Saurin; F Artiguenave; P Brottier; T Bruls; E Pelletier; C Robert; P Wincker; D R Smith; L Doucette-Stamm; M Rubenfield; K Weinstock; H M Lee; J Dubois; A Rosenthal; M Platzer; G Nyakatura; S Taudien; A Rump; H Yang; J Yu; J Wang; G Huang; J Gu; L Hood; L Rowen; A Madan; S Qin; R W Davis; N A Federspiel; A P Abola; M J Proctor; R M Myers; J Schmutz; M Dickson; J Grimwood; D R Cox; M V Olson; R Kaul; C Raymond; N Shimizu; K Kawasaki; S Minoshima; G A Evans; M Athanasiou; R Schultz; B A Roe; F Chen; H Pan; J Ramser; H Lehrach; R Reinhardt; W R McCombie; M de la Bastide; N Dedhia; H Blöcker; K Hornischer; G Nordsiek; R Agarwala; L Aravind; J A Bailey; A Bateman; S Batzoglou; E Birney; P Bork; D G Brown; C B Burge; L Cerutti; H C Chen; D Church; M Clamp; R R Copley; T Doerks; S R Eddy; E E Eichler; T S Furey; J Galagan; J G Gilbert; C Harmon; Y Hayashizaki; D Haussler; H Hermjakob; K Hokamp; W Jang; L S Johnson; T A Jones; S Kasif; A Kaspryzk; S Kennedy; W J Kent; P Kitts; E V Koonin; I Korf; D Kulp; D Lancet; T M Lowe; A McLysaght; T Mikkelsen; J V Moran; N Mulder; V J Pollara; C P Ponting; G Schuler; J Schultz; G Slater; A F Smit; E Stupka; J Szustakowki; D Thierry-Mieg; J Thierry-Mieg; L Wagner; J Wallis; R Wheeler; A Williams; Y I Wolf; K H Wolfe; S P Yang; R F Yeh; F Collins; M S Guyer; J Peterson; A Felsenfeld; K A Wetterstrand; A Patrinos; M J Morgan; P de Jong; J J Catanese; K Osoegawa; H Shizuya; S Choi; Y J Chen; J Szustakowki
Journal:  Nature       Date:  2001-02-15       Impact factor: 49.962

Review 3.  Vaccine-derived polioviruses and the endgame strategy for global polio eradication.

Authors:  Olen M Kew; Roland W Sutter; Esther M de Gourville; Walter R Dowdle; Mark A Pallansch
Journal:  Annu Rev Microbiol       Date:  2005       Impact factor: 15.500

4.  Conclusions and recommendations of the Ad Hoc Advisory Committee on Poliomyelitis Eradication, Geneva, 21-22 September 2004.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2004-11-05

Review 5.  Risk management in a polio-free world.

Authors:  R Bruce Aylward; Roland W Sutter; Steve L Cochi; Kimberly M Thompson; Hamid Jafari; David Heymann
Journal:  Risk Anal       Date:  2006-12       Impact factor: 4.000

6.  Interrupting poliovirus transmission -- new solutions to an old problem.

Authors:  R Bruce Aylward; Chris Maher
Journal:  Biologicals       Date:  2006-05-08       Impact factor: 1.856

7.  Polio today: are we on the verge of global eradication?

Authors:  Stephen L Cochi; Olen Kew
Journal:  JAMA       Date:  2008-08-20       Impact factor: 56.272

8.  The last mile in global poliomyelitis eradication.

Authors:  Zulfiqar A Bhutta
Journal:  Lancet       Date:  2011-06-12       Impact factor: 79.321

9.  Diplomacy and the polio immunization boycott in Northern Nigeria.

Authors:  Judith R Kaufmann; Harley Feldbaum
Journal:  Health Aff (Millwood)       Date:  2009 Jul-Aug       Impact factor: 6.301

10.  Paralytic poliomyelitis: seasoned strategies, disappearing disease.

Authors:  H F Hull; N A Ward; B P Hull; J B Milstien; C de Quadros
Journal:  Lancet       Date:  1994-05-28       Impact factor: 79.321

View more
  4 in total

1.  Do Maternal Living Arrangements Influence the Vaccination Status of Children Age 12-23 Months? A Data Analysis of Demographic Health Surveys 2010-11 from Zimbabwe.

Authors:  Rodolfo Rossi
Journal:  PLoS One       Date:  2015-07-13       Impact factor: 3.240

2.  Intensified Local Resource Mobilization for the Polio Eradication Initiative: The Experience of World Health Organization in Nigeria During 2008-2015.

Authors:  Yared G Yehualashet; Janet Horton; Pascal Mkanda; Rui G Vaz; Oluwole Afolabi; Sisay G Gashu; Richard Banda; Helena O'Malley; Peter Nsubuga
Journal:  J Infect Dis       Date:  2016-02-23       Impact factor: 5.226

3.  Political will and international collaborative frameworks in infectious diseases.

Authors:  R A Stein
Journal:  Int J Clin Pract       Date:  2015-01       Impact factor: 2.503

Review 4.  Eradication and Current Status of Poliomyelitis in Pakistan: Ground Realities.

Authors:  Shazia Ghafoor; Nadeem Sheikh
Journal:  J Immunol Res       Date:  2016-07-18       Impact factor: 4.818

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.